Showing 17,801 - 17,820 results of 45,793 for search '(( 5 ((step decrease) OR (mean decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 0.83s Refine Results
  1. 17801
  2. 17802

    Effects of pressure support and pressure-controlled ventilation on lung damage in a model of mild extrapulmonary acute lung injury with intra-abdominal hypertension by Cintia L. Santos (4047562)

    Published 2017
    “…Regardless of whether IAH was present, PSV resulted in lower mean airway pressure (with no differences in peak airway or peak and mean transpulmonary pressures) and less mRNA expression of biomarkers associated with lung inflammation (IL-6) and fibrogenesis (type III procollagen) than PCV. …”
  3. 17803

    dPRPS plays a critical function during cellular response to oxidative stress. by Keemo Delos Santos (7349087)

    Published 2019
    “…<p>(A) Ovaries (upper panel) or fat bodies (lower panel) of adult <i>dPRPS GFP-trap</i> flies fed with PBS or PQT are immunostained for GFP (green) and DAPI (blue). …”
  4. 17804

    B[a]P treatment results in modulation of intracellular phosphop38 MAP kinase. by Kallol Dutta (215291)

    Published 2010
    “…Similarly, phosphoP38 MAP kinase level in 0.2 µM B[a]P treated group after 24 h, was significantly decreased as compared to that in 12 h post treatment group. …”
  5. 17805

    A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia by Nagore I. Marín-Ramos (1600555)

    Published 2019
    “…In this work we report a potent ICMT inhibitor, compound <b>3</b> [UCM-1336, IC<sub>50</sub> = 2 μM], which is selective against the other enzymes involved in the post-translational modifications of Ras. …”
  6. 17806

    A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia by Nagore I. Marín-Ramos (1600555)

    Published 2019
    “…In this work we report a potent ICMT inhibitor, compound <b>3</b> [UCM-1336, IC<sub>50</sub> = 2 μM], which is selective against the other enzymes involved in the post-translational modifications of Ras. …”
  7. 17807

    A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia by Nagore I. Marín-Ramos (1600555)

    Published 2019
    “…In this work we report a potent ICMT inhibitor, compound <b>3</b> [UCM-1336, IC<sub>50</sub> = 2 μM], which is selective against the other enzymes involved in the post-translational modifications of Ras. …”
  8. 17808

    Trypacidin, a Spore-Borne Toxin from <em>Aspergillus fumigatus</em>, Is Cytotoxic to Lung Cells by Thierry Gauthier (185229)

    Published 2012
    “…Trypacidin was the most toxic, decreasing cell viability and triggering cell lysis, both effects occurring at an IC<sub>50</sub> close to 7 µM. …”
  9. 17809
  10. 17810

    Knockdown of nr2f1a causes defects in zebrafish vascular development. by Bao-Jueng Wu (621818)

    Published 2014
    “…At the same stage ISVs are stalled at mid-somite in nr2f1a<sup>e2i2</sup> morphants (<b>D, F</b>). (<b>I</b>) Quantification of percentage of completed ISV shows a50% increase compared to <i>nr2f1a</i> morphants (n = 26 in wt and n = 34 in nr2f1aMO) at 30 hpf. …”
  11. 17811

    Parity and Pancreatic Cancer Risk: A Dose-Response Meta-Analysis of Epidemiologic Studies by Hong-Bo Guan (464993)

    Published 2014
    “…</p><p>Conclusion</p><p>In summary, these findings suggest that higher parity is associated with a decreased risk of PC. Future large consortia or pooled studies are warranted to fully adjust for potential confounders to confirm this association.…”
  12. 17812

    S2 Data - by Tamara Mogilevski (14239682)

    Published 2024
    “…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
  13. 17813

    Study protocol. by Tamara Mogilevski (14239682)

    Published 2024
    “…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
  14. 17814

    S1 Data - by Tamara Mogilevski (14239682)

    Published 2024
    “…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
  15. 17815
  16. 17816
  17. 17817
  18. 17818

    Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnea Syndrome: A Randomized Clinical Trial by Kang Wu (160544)

    Published 2016
    “…The CPAP group also showed a decreased oxygen desaturation index and a significant increase in the mean oxygen saturation after treatment, but these increases were not observed in the carbocysteine group. …”
  19. 17819

    Image_2_A comparison of rat models that best mimic immune-driven preeclampsia in humans.jpeg by Fahmida Jahan (17057388)

    Published 2023
    “…Of the three rodent models tested, we found that Poly I:C and LPS decreased both fetal weight and survival; and correlated with a reduction in region specific placenta growth. …”
  20. 17820

    Image_1_A comparison of rat models that best mimic immune-driven preeclampsia in humans.jpeg by Fahmida Jahan (17057388)

    Published 2023
    “…Of the three rodent models tested, we found that Poly I:C and LPS decreased both fetal weight and survival; and correlated with a reduction in region specific placenta growth. …”